Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Walnut Creek, California 94598


Purpose:

This is an open-label, exploratory pilot study in patients with T1D. The study will involve two daytime clinical research center visits 7-14 days apart. Subjects will receive a single injection of G-Pen™ (glucagon injection) at each visit.


Criteria:

Inclusion Criteria: - Type 1 diabetes mellitus for at least 24 months Exclusion Criteria: - Pregnant or Lactating - HbA1c >10.5% at screening - Use of > 2.0 U/kg total insulin dose per day - Inadequate bilateral venous access in both arms - Renal insufficiency - Congestive heart failure, NYHA class II, III or IV - Active malignancy within 5 years from screening - Major surgical operation within 30 days prior to screening - Seizure or bleeding disorder - Glycogen storage disease - Active substance or alchohol abuse


NCT ID:

NCT02423980


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Walnut Creek, California 94598
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 24, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.